Kadcyla

Ado-Trastuzumab Emtansine

7.4 High risk

Kadcyla & Death

6.1%

of users reported Death

94.9%

also reported Death

94.4%

are women

Most common medical consequences

Death
94.9%
Severe reaction
4.5%
Hospitalization
0.6%

Have you experienced any negative side effects from this medication?

Kadcyla: general information

Most common side effects (87)

Most commonly affected ages

20 - 29 years
1.3%
30 - 39 years
10.5%
40 - 49 years
22.7%
50 - 59 years
31.3%
60 - 69 years
24.8%
70 - 79 years
9.1%
80 - 89 years
0.5%